dc.contributor.editor | Zarros A | |
dc.contributor.editor | Jones EM | |
dc.contributor.editor | Tansey EM | |
dc.date.accessioned | 2017-06-08T13:28:21Z | |
dc.date.available | 2017-06-08T13:28:21Z | |
dc.date.issued | 2016 | |
dc.date.submitted | 2017-06-08T12:29:12.496Z | |
dc.identifier.isbn | 9781910195208 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23681 | |
dc.description.abstract | With an introduction by Professor Jon Cohen, this Witness Seminar focuses on the recent history of TNF and its identification as a therapeutic target for rheumatoid arthritis and other diseases. The participants provide insights into how TNF has become a focal point for the study of inflammatory and malignant diseases, and discuss the obstacles and the opportunities that arose during the development of anti-TNF drugs. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartofseries | Wellcome Witnesses to Contemporary Medicine;Volume 60 | |
dc.subject | Wellcome Witnesses to Contemporary Medicine | en_US |
dc.subject | History of Modern Biomedicine Research Group | en_US |
dc.title | The Recent History of Tumour Necrosis Factor (TNF) | en_US |
dc.type | Book | en_US |